INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 38 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,077,000 | +55.9% | 13,500,000 | +58.8% | 0.08% | +46.4% |
| Q4 2020 | $9,668,000 | +4.7% | 8,500,000 | 0.0% | 0.06% | -5.1% |
| Q3 2020 | $9,232,000 | +11.4% | 8,500,000 | 0.0% | 0.06% | 0.0% |
| Q2 2020 | $8,286,000 | -34.8% | 8,500,000 | -44.0% | 0.06% | -41.0% |
| Q1 2020 | $12,704,000 | -21.3% | 15,171,000 | -9.0% | 0.10% | +25.0% |
| Q4 2019 | $16,133,000 | -3.8% | 16,671,000 | -16.7% | 0.08% | -12.1% |
| Q3 2019 | $16,764,000 | -13.9% | 20,004,000 | 0.0% | 0.09% | -15.7% |
| Q2 2019 | $19,470,000 | -3.5% | 20,004,000 | 0.0% | 0.11% | -14.3% |
| Q1 2019 | $20,183,000 | +42.5% | 20,004,000 | +0.0% | 0.13% | +35.5% |
| Q4 2018 | $14,164,000 | -17.0% | 20,000,000 | 0.0% | 0.09% | -1.1% |
| Q3 2018 | $17,065,000 | -6.8% | 20,000,000 | 0.0% | 0.09% | -16.1% |
| Q2 2018 | $18,304,000 | +2.8% | 20,000,000 | 0.0% | 0.11% | -3.4% |
| Q1 2018 | $17,798,000 | – | 20,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |